Inhibiting glutamine uptake represents an attractive new strategy for treating acute myeloid leukemiaLise Willems, Didier Bouscary, Alain Schmitt et al.|Blood|2013Cited by 286
Protein synthesis is resistant to rapamycin and constitutes a promising therapeutic target in acute myeloid leukemiaJérôme Tamburini, Didier Bouscary, Alexa S. Green et al.|Blood|2009Cited by 185
Minimal residual disease quantification in ovarian tissue collected from patients in complete remission of acute leukemiaFlorian Chevillon, Nathalie Dhédin, Emmanuelle Clappier et al.|Blood|2020Cited by 30